REVIEWS AND NEWS
SPREAD THE WORD
Find out what people are saying about Regulora.
REGULORA
IN THE NEWS
Our headway is making headlines.
Gut Feelings: Gastropsychology offers fresh take on ‘dysregulated’ brain-gut crosstalk
This article describes the important role prescription digital therapeutics can play when access to gastropsychological services is limited.
Gut Directed Hypnosis and IBS Management
Listen to UNC-Chapel Hill’s Dr. Olafur Palsson, originator of the gold-standard North Carolina treatment protocol for gut-directed hypnotherapy (GDH), talk about the data that support the use of GDH…
JOIN THE CONVERSATION
Follow us on social media
FOSTERING BETTER
MIND-GUT
COMMUNICATION
GDH has been helping IBS
patients find relief for nearly
four decades.1
READY TO
RETHINK IBS PAIN?
.
Consider a safe and effective
non-pharmacological
option.2-4
PRESCRIBING
MADE SIMPLE
.
.
EDUCATE YOUR
PATIENTS ON THE
BENEFITS OF REGULORA
Get answers to questions
your patients may ask.
.
JOIN THE REGULORA REVOLUTION
Sign up and stay on the cutting edge of prescription digital therapy.
References:
- Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022;15:17562848221074208.
- Regulora® Instructions for Use for Patients and Physicians. metaMe Health, Inc.; April 2022.
- The Rome Foundation. Brain-Gut Psychotherapy Referral Guide. Accessed July 29, 2022. https://theromefoundation.org/wp-content/uploads/Rome-Foundation_GastroPsych-referral-project.pdf
- Miller V, Carruthers HR, Morris J, et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41(9):844-855.
IMPORTANT INFORMATION
Regulora® is a prescription-only digital therapeutic device intended to provide behavioral therapy through gut-directed hypnotherapy for adults 22 years of age and older who have been diagnosed with irritable bowel syndrome (IBS). Regulora is indicated as a 3-month treatment for patients with abdominal pain due to IBS and is intended to be used together with other IBS treatments.
US federal law restricts this mobile application device to sale by or on the order of a physician. Regulora is intended for patients who speak and read English. Regulora may not be appropriate for patients with mental or physical impairment that would prevent interacting with a mobile video application. Regulora may not be appropriate for patients with evidence of intestinal illness that better explains IBS symptoms such as celiac disease or inflammatory bowel disease. Regulora should not be used in lieu of your patient’s current IBS medication or therapy. In a clinical trial of Regulora, side effects were low. About 1% of patients experienced abdominal pain, constipation, fatigue, or headache which was thought to be related to using Regulora.